{"count": 10, "results": [{"_id": "34692306", "pmid": 34692306, "pmcid": "PMC8525664", "title": "The Effectiveness of Statins as Potential Therapy for Multiple Sclerosis: A Systematic Review of Randomized Controlled trials", "journal": "Cureus", "authors": ["Abdalla MA", "Zakhary CM", "Rushdi H", "Hamdan JA", "Youssef KN", "Khan A", "Khan S"], "date": "2021-09-19T00:00:00Z", "doi": "10.7759/cureus.18092", "meta_date_publication": "2021 Sep", "meta_volume": "13", "meta_issue": "9", "meta_pages": "e18092", "score": 50281.34, "text_hl": "For the @<m>DISEASE_Multiple_Sclerosis_Chronic_Progressive</m> @DISEASE_MESH:D020528 @@@SPMS@@@ trial, Chataway and co-authors presented the difference in EDSS at 24 months between @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and placebo groups.", "citations": {"NLM": "Abdalla MA, Zakhary CM, Rushdi H, Hamdan JA, Youssef KN, Khan A, Khan S. The Effectiveness of Statins as Potential Therapy for Multiple Sclerosis: A Systematic Review of Randomized Controlled trials Cureus. 2021 Sep;13(9):e18092. PMID: 34692306", "BibTeX": "@article{34692306, title={The Effectiveness of Statins as Potential Therapy for Multiple Sclerosis: A Systematic Review of Randomized Controlled trials}, author={Abdalla MA and Zakhary CM and Rushdi H and Hamdan JA and Youssef KN and Khan A and Khan S}, journal={Cureus}, volume={13}, number={9}, pages={e18092}}"}}, {"_id": "35743410", "pmid": 35743410, "title": "Novel Drugs in a Pipeline for Progressive Multiple Sclerosis.", "journal": "J Clin Med", "authors": ["Sapko K", "Jamroz-Wiśniewska A", "Rejdak K"], "date": "2022-06-10T00:00:00Z", "doi": "10.3390/jcm11123342", "meta_date_publication": "2022 Jun 10", "meta_volume": "11", "meta_issue": "12", "meta_pages": "", "score": 50278.92, "text_hl": "Novel Drugs in a Pipeline for @<m>DISEASE_Multiple_Sclerosis_Chronic_Progressive</m> @DISEASE_MESH:D020528 @@@Progressive Multiple Sclerosis@@@.", "citations": {"NLM": "Sapko K, Jamroz-Wiśniewska A, Rejdak K. Novel Drugs in a Pipeline for Progressive Multiple Sclerosis. J Clin Med. 2022 Jun 10;11(12):. PMID: 35743410", "BibTeX": "@article{35743410, title={Novel Drugs in a Pipeline for Progressive Multiple Sclerosis.}, author={Sapko K and Jamroz-Wiśniewska A and Rejdak K}, journal={J Clin Med}, volume={11}, number={12}}"}}, {"_id": "39437792", "pmid": 39437792, "title": "Increased cholesterol synthesis drives neurotoxicity in patient stem cell-derived model of multiple sclerosis.", "journal": "Cell Stem Cell", "authors": ["Ionescu RB", "Nicaise AM", "Reisz JA", "Williams EC", "Prasad P", "Willis CM", "Simões-Abade MBC", "Sbarro L", "Dzieciatkowska M", "Stephenson D", "Suarez Cubero M", "Rizzi S", "Pirvan L", "Peruzzotti-Jametti L", "Fossati V", "Edenhofer F", "Leonardi T", "Frezza C", "Mohorianu I", "D'Alessandro A", "Pluchino S"], "date": "2024-10-14T00:00:00Z", "doi": "10.1016/j.stem.2024.09.014", "meta_date_publication": "2024 Oct 14", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50260.84, "text_hl": "SASP from @<m>DISEASE_Multiple_Sclerosis_Chronic_Progressive</m> @DISEASE_MESH:D020528 @@@PMS@@@ iNSC lines induced @DISEASE_Neurotoxicity_Syndromes @DISEASE_MESH:D020258 @@@neurotoxicity@@@ in mature neurons, and treatment with the @GENE_HMGCR @GENE_3156 @@@HMGCR@@@ inhibitor @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ altered the @<m>DISEASE_Multiple_Sclerosis_Chronic_Progressive</m> @DISEASE_MESH:D020528 @@@PMS@@@ iNSC SASP, promoting cytoprotective qualities and reducing @DISEASE_Neurotoxicity_Syndromes @DISEASE_MESH:D020258 @@@neurotoxicity@@@. ", "citations": {"NLM": "Ionescu RB, Nicaise AM, Reisz JA, Williams EC, Prasad P, Willis CM, Simões-Abade MBC, Sbarro L, Dzieciatkowska M, Stephenson D, Suarez Cubero M, Rizzi S, Pirvan L, Peruzzotti-Jametti L, Fossati V, Edenhofer F, Leonardi T, Frezza C, Mohorianu I, D'Alessandro A, Pluchino S. Increased cholesterol synthesis drives neurotoxicity in patient stem cell-derived model of multiple sclerosis. Cell Stem Cell. 2024 Oct 14;():. PMID: 39437792", "BibTeX": "@article{39437792, title={Increased cholesterol synthesis drives neurotoxicity in patient stem cell-derived model of multiple sclerosis.}, author={Ionescu RB and Nicaise AM and Reisz JA and Williams EC and Prasad P and Willis CM and Simões-Abade MBC and Sbarro L and Dzieciatkowska M and Stephenson D and Suarez Cubero M and Rizzi S and Pirvan L and Peruzzotti-Jametti L and Fossati V and Edenhofer F and Leonardi T and Frezza C and Mohorianu I and D'Alessandro A and Pluchino S}, journal={Cell Stem Cell}}"}}, {"_id": "39284697", "pmid": 39284697, "title": "Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.", "journal": "BMJ Open", "authors": ["Blackstone J", "Williams T", "Nicholas JM", "Bordea E", "De Angelis F", "Bianchi A", "Calvi A", "Doshi A", "John N", "Apap Mangion S", "Wade C", "Merry R", "Barton G", "Lyle D", "Jarman E", "Mahad D", "Shehu A", "Arun T", "McDonnell G", "Geraldes R", "Craner M", "Hillier C", "Ganesalingam J", "Fisniku L", "Hobart J", "Spilker C", "Robertson N", "Kalra S", "Pluchino S", "Harikrishnan S", "Mattoscio M", "Harrower T", "Young C", "Lee M", "Chhetri S", "Ahmed F", "Rog D", "Silber E", "Gallagher P", "Duddy M", "Straukiene A", "Nicholas R", "Rice C", "Nixon SJ", "Beveridge J", "Hawton A", "Tebbs S", "Braisher M", "Giovannoni G", "Ciccarelli O", "Greenwood J", "Thompson AJ", "Hunter R", "Pavitt S", "Pearson O", "Evangelou N", "Sharrack B", "Galea I", "Chandran S", "Ford HL", "Frost C", "Chataway J"], "date": "2024-09-16T00:00:00Z", "doi": "10.1136/bmjopen-2024-086414", "meta_date_publication": "2024 Sep 16", "meta_volume": "14", "meta_issue": "9", "meta_pages": "e086414", "score": 50255.418, "text_hl": "INTRODUCTION: There remains a high unmet need for disease-modifying therapies that can impact @DISEASE_Movement_Disorders @DISEASE_MESH:D009069 @@@disability@@@ progression in secondary progressive @DISEASE_Multiple_Sclerosis @DISEASE_MESH:D009103 @@@multiple sclerosis@@@ (@<m>DISEASE_Multiple_Sclerosis_Chronic_Progressive</m> @DISEASE_MESH:D020528 @@@SPMS@@@). Following positive results of the phase 2 @DISEASE_Multiple_Sclerosis @DISEASE_MESH:D009103 @@@MS@@@-STAT study, the @DISEASE_Multiple_Sclerosis @DISEASE_MESH:D009103 @@@MS@@@-@GENE_STAT2 @GENE_6773 @@@STAT2@@@ phase 3 trial will evaluate the efficacy and cost-effectiveness of repurposed high-dose @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in slowing the progression of @DISEASE_Movement_Disorders @DISEASE_MESH:D009069 @@@disability@@@ in @<m>DISEASE_Multiple_Sclerosis_Chronic_Progressive</m> @DISEASE_MESH:D020528 @@@SPMS@@@. ", "citations": {"NLM": "Blackstone J, Williams T, Nicholas JM, Bordea E, De Angelis F, Bianchi A, Calvi A, Doshi A, John N, Apap Mangion S, Wade C, Merry R, Barton G, Lyle D, Jarman E, Mahad D, Shehu A, Arun T, McDonnell G, Geraldes R, Craner M, Hillier C, Ganesalingam J, Fisniku L, Hobart J, Spilker C, Robertson N, Kalra S, Pluchino S, Harikrishnan S, Mattoscio M, Harrower T, Young C, Lee M, Chhetri S, Ahmed F, Rog D, Silber E, Gallagher P, Duddy M, Straukiene A, Nicholas R, Rice C, Nixon SJ, Beveridge J, Hawton A, Tebbs S, Braisher M, Giovannoni G, Ciccarelli O, Greenwood J, Thompson AJ, Hunter R, Pavitt S, Pearson O, Evangelou N, Sharrack B, Galea I, Chandran S, Ford HL, Frost C, Chataway J. Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK. BMJ Open. 2024 Sep 16;14(9):e086414. PMID: 39284697", "BibTeX": "@article{39284697, title={Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.}, author={Blackstone J and Williams T and Nicholas JM and Bordea E and De Angelis F and Bianchi A and Calvi A and Doshi A and John N and Apap Mangion S and Wade C and Merry R and Barton G and Lyle D and Jarman E and Mahad D and Shehu A and Arun T and McDonnell G and Geraldes R and Craner M and Hillier C and Ganesalingam J and Fisniku L and Hobart J and Spilker C and Robertson N and Kalra S and Pluchino S and Harikrishnan S and Mattoscio M and Harrower T and Young C and Lee M and Chhetri S and Ahmed F and Rog D and Silber E and Gallagher P and Duddy M and Straukiene A and Nicholas R and Rice C and Nixon SJ and Beveridge J and Hawton A and Tebbs S and Braisher M and Giovannoni G and Ciccarelli O and Greenwood J and Thompson AJ and Hunter R and Pavitt S and Pearson O and Evangelou N and Sharrack B and Galea I and Chandran S and Ford HL and Frost C and Chataway J}, journal={BMJ Open}, volume={14}, number={9}, pages={e086414}}"}}, {"_id": "35216778", "pmid": 35216778, "title": "The effects of HMG-CoA reductase inhibitors on disease activity in multiple sclerosis: A systematic review and meta-analysis.", "journal": "Mult Scler Relat Disord", "authors": ["Stefanou MI", "Palaiodimou L", "Katsanos AH", "Milionis H", "Kosmidou M", "Lambadiari V", "Halvatsiotis P", "Ferentinos P", "Andreadou E", "Marinos G", "Theodorou A", "Tzartos JS", "Voumvourakis K", "Tsivgoulis G", "Giannopoulos S"], "date": "2022-02-01T00:00:00Z", "doi": "10.1016/j.msard.2021.103395", "meta_date_publication": "2022 Feb", "meta_volume": "58", "meta_issue": "", "meta_pages": "103395", "score": 50250.76, "text_hl": "Add-on statins to @GENE_IFNB1 @GENE_3456 @@@IFN-beta@@@ were safe and well-tolerated. In @<m>DISEASE_Multiple_Sclerosis_Chronic_Progressive</m> @DISEASE_MESH:D020528 @@@SPMS@@@, stand-alone @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ led to significantly reduced annualized rate of whole-brain @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@volume reduction@@@. ", "citations": {"NLM": "Stefanou MI, Palaiodimou L, Katsanos AH, Milionis H, Kosmidou M, Lambadiari V, Halvatsiotis P, Ferentinos P, Andreadou E, Marinos G, Theodorou A, Tzartos JS, Voumvourakis K, Tsivgoulis G, Giannopoulos S. The effects of HMG-CoA reductase inhibitors on disease activity in multiple sclerosis: A systematic review and meta-analysis. Mult Scler Relat Disord. 2022 Feb;58():103395. PMID: 35216778", "BibTeX": "@article{35216778, title={The effects of HMG-CoA reductase inhibitors on disease activity in multiple sclerosis: A systematic review and meta-analysis.}, author={Stefanou MI and Palaiodimou L and Katsanos AH and Milionis H and Kosmidou M and Lambadiari V and Halvatsiotis P and Ferentinos P and Andreadou E and Marinos G and Theodorou A and Tzartos JS and Voumvourakis K and Tsivgoulis G and Giannopoulos S}, journal={Mult Scler Relat Disord}, volume={58}, pages={103395}}"}}, {"_id": "39328985", "pmid": 39328985, "title": "Investigating the relationship between thalamic iron concentration and disease severity in secondary progressive multiple sclerosis using quantitative susceptibility mapping: Cross-sectional analysis from the MS-STAT2 randomised controlled trial.", "journal": "Neuroimage Rep", "authors": ["Williams T", "John N", "Calvi A", "Bianchi A", "De Angelis F", "Doshi A", "Wright S", "Shatila M", "Yiannakas MC", "Chowdhury F", "Stutters J", "Ricciardi A", "Prados F", "MacManus D", "Grussu F", "Karsa A", "Samson B", "Battiston M", "Gandini Wheeler-Kingshott CAM", "Shmueli K", "Ciccarelli O", "Barkhof F", "Chataway J", "UCL MS-STAT2 investigators"], "date": "2024-09-01T00:00:00Z", "doi": "10.1016/j.ynirp.2024.100216", "meta_date_publication": "2024 Sep", "meta_volume": "4", "meta_issue": "3", "meta_pages": "100216", "score": 50249.035, "text_hl": "Methods: Baseline data from a subgroup of the MS-@GENE_STAT2 @GENE_6773 @@@STAT2@@@ trial (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ vs. placebo in @<m>DISEASE_Multiple_Sclerosis_Chronic_Progressive</m> @DISEASE_MESH:D020528 @@@SPMS@@@, NCT03387670) were included. ", "citations": {"NLM": "Williams T, John N, Calvi A, Bianchi A, De Angelis F, Doshi A, Wright S, Shatila M, Yiannakas MC, Chowdhury F, Stutters J, Ricciardi A, Prados F, MacManus D, Grussu F, Karsa A, Samson B, Battiston M, Gandini Wheeler-Kingshott CAM, Shmueli K, Ciccarelli O, Barkhof F, Chataway J, UCL MS-STAT2 investigators. Investigating the relationship between thalamic iron concentration and disease severity in secondary progressive multiple sclerosis using quantitative susceptibility mapping: Cross-sectional analysis from the MS-STAT2 randomised controlled trial. Neuroimage Rep. 2024 Sep;4(3):100216. PMID: 39328985", "BibTeX": "@article{39328985, title={Investigating the relationship between thalamic iron concentration and disease severity in secondary progressive multiple sclerosis using quantitative susceptibility mapping: Cross-sectional analysis from the MS-STAT2 randomised controlled trial.}, author={Williams T and John N and Calvi A and Bianchi A and De Angelis F and Doshi A and Wright S and Shatila M and Yiannakas MC and Chowdhury F and Stutters J and Ricciardi A and Prados F and MacManus D and Grussu F and Karsa A and Samson B and Battiston M and Gandini Wheeler-Kingshott CAM and Shmueli K and Ciccarelli O and Barkhof F and Chataway J and UCL MS-STAT2 investigators}, journal={Neuroimage Rep}, volume={4}, number={3}, pages={100216}}"}}, {"_id": "24655729", "pmid": 24655729, "title": "Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial.", "journal": "Lancet", "authors": ["Chataway J", "Schuerer N", "Alsanousi A", "Chan D", "MacManus D", "Hunter K", "Anderson V", "Bangham CR", "Clegg S", "Nielsen C", "Fox NC", "Wilkie D", "Nicholas JM", "Calder VL", "Greenwood J", "Frost C", "Nicholas R"], "date": "2014-06-28T00:00:00Z", "doi": "10.1016/S0140-6736(13)62242-4", "meta_date_publication": "2014 Jun 28", "meta_volume": "383", "meta_issue": "9936", "meta_pages": "2213-21", "score": 50063.92, "text_hl": "@SPECIES_9606 @@@Patients@@@ aged 18-65 years with @<m>DISEASE_Multiple_Sclerosis_Chronic_Progressive</m> @DISEASE_MESH:D020528 @@@secondary progressive multiple sclerosis@@@ were randomly assigned (1:1), by a centralised web-based service with a block size of eight, to receive either 80 mg of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ or placebo. ", "citations": {"NLM": "Chataway J, Schuerer N, Alsanousi A, Chan D, MacManus D, Hunter K, Anderson V, Bangham CR, Clegg S, Nielsen C, Fox NC, Wilkie D, Nicholas JM, Calder VL, Greenwood J, Frost C, Nicholas R. Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial. Lancet. 2014 Jun 28;383(9936):2213-21. PMID: 24655729", "BibTeX": "@article{24655729, title={Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial.}, author={Chataway J and Schuerer N and Alsanousi A and Chan D and MacManus D and Hunter K and Anderson V and Bangham CR and Clegg S and Nielsen C and Fox NC and Wilkie D and Nicholas JM and Calder VL and Greenwood J and Frost C and Nicholas R}, journal={Lancet}, volume={383}, number={9936}, pages={2213-21}}"}}, {"_id": "31072935", "pmid": 31072935, "pmcid": "PMC6561162", "title": "Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis", "journal": "Proc Natl Acad Sci U S A", "authors": ["Eshaghi A", "Kievit RA", "Prados F", "Sudre CH", "Nicholas J", "Cardoso MJ", "Chan D", "Nicholas R", "Ourselin S", "Greenwood J", "Thompson AJ", "Alexander DC", "Barkhof F", "Chataway J", "Ciccarelli O"], "date": "2019-05-28T00:00:00Z", "doi": "10.1073/pnas.1818978116", "meta_date_publication": "2019 May 28", "meta_volume": "116", "meta_issue": "22", "meta_pages": "11020-11027", "score": 50061.824, "text_hl": "We applied structural equation models to the @DISEASE_Multiple_Sclerosis @DISEASE_MESH:D009103 @@@MS@@@-STAT trial in which 140 @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Multiple_Sclerosis_Chronic_Progressive</m> @DISEASE_MESH:D020528 @@@SPMS@@@ were randomized to receive placebo or @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@. ", "citations": {"NLM": "Eshaghi A, Kievit RA, Prados F, Sudre CH, Nicholas J, Cardoso MJ, Chan D, Nicholas R, Ourselin S, Greenwood J, Thompson AJ, Alexander DC, Barkhof F, Chataway J, Ciccarelli O. Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis Proc Natl Acad Sci U S A. 2019 May 28;116(22):11020-11027. PMID: 31072935", "BibTeX": "@article{31072935, title={Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis}, author={Eshaghi A and Kievit RA and Prados F and Sudre CH and Nicholas J and Cardoso MJ and Chan D and Nicholas R and Ourselin S and Greenwood J and Thompson AJ and Alexander DC and Barkhof F and Chataway J and Ciccarelli O}, journal={Proc Natl Acad Sci U S A}, volume={116}, number={22}, pages={11020-11027}}"}}, {"_id": "28600189", "pmid": 28600189, "pmcid": "PMC5507768", "title": "Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial", "journal": "Lancet Neurol", "authors": ["Chan D", "Binks S", "Nicholas JM", "Frost C", "Cardoso MJ", "Ourselin S", "Wilkie D", "Nicholas R", "Chataway J"], "date": "2017-08-01T00:00:00Z", "doi": "10.1016/S1474-4422(17)30113-8", "meta_date_publication": "2017 Aug", "meta_volume": "16", "meta_issue": "8", "meta_pages": "591-600", "score": 50059.473, "text_hl": "@DISEASE_Multiple_Sclerosis @DISEASE_MESH:D009103 @@@MS-STAT@@@ was a phase 2 trial of high-dose @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (80 mg) in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Multiple_Sclerosis_Chronic_Progressive</m> @DISEASE_MESH:D020528 @@@SPMS@@@. ", "citations": {"NLM": "Chan D, Binks S, Nicholas JM, Frost C, Cardoso MJ, Ourselin S, Wilkie D, Nicholas R, Chataway J. Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial Lancet Neurol. 2017 Aug;16(8):591-600. PMID: 28600189", "BibTeX": "@article{28600189, title={Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial}, author={Chan D and Binks S and Nicholas JM and Frost C and Cardoso MJ and Ourselin S and Wilkie D and Nicholas R and Chataway J}, journal={Lancet Neurol}, volume={16}, number={8}, pages={591-600}}"}}, {"_id": "29627873", "pmid": 29627873, "title": "Disease-Modifying Treatment in Progressive Multiple Sclerosis.", "journal": "Curr Treat Options Neurol", "authors": ["Ciotti JR", "Cross AH"], "date": "2018-04-07T00:00:00Z", "doi": "10.1007/s11940-018-0496-3", "meta_date_publication": "2018 Apr 7", "meta_volume": "20", "meta_issue": "5", "meta_pages": "12", "score": 50057.582, "text_hl": "Smaller early phase studies of @CHEMICAL_Thioctic_Acid @CHEMICAL_MESH:D008063 @@@alpha-lipoic acid@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ each found slowing of rate of whole @DISEASE_Microphthalmia_Syndromic_10 @DISEASE_MESH:C566985 @@@brain atrophy@@@ in @<m>DISEASE_Multiple_Sclerosis_Chronic_Progressive</m> @DISEASE_MESH:D020528 @@@SPMS@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Ciotti JR, Cross AH. Disease-Modifying Treatment in Progressive Multiple Sclerosis. Curr Treat Options Neurol. 2018 Apr 7;20(5):12. PMID: 29627873", "BibTeX": "@article{29627873, title={Disease-Modifying Treatment in Progressive Multiple Sclerosis.}, author={Ciotti JR and Cross AH}, journal={Curr Treat Options Neurol}, volume={20}, number={5}, pages={12}}"}}]}